13F filer · CIK 1983313
Cutter Capital Management, LP
NEW YORK, NY · filing since Q4 2023 · last filing Jul 24, 2025
Reported value
$0
$-229.6M vs prior
Positions
1
New / sold out
1 / 21
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $229.6M
Top-10 weight
–
Biggest buys vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | N/A | 0 | – | – |
Biggest sells vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | BRISTOL-MYERS SQUIBB CO | -295,000 | -100.0% | $-18.0M |
| Sold out | AMGEN INC | -50,000 | -100.0% | $-15.6M |
| Sold out | BIOGEN INC | -113,500 | -100.0% | $-15.5M |
| Sold out | LLYELI LILLY & CO | -18,000 | -100.0% | $-14.9M |
| Sold out | INSMED INC | -186,384 | -100.0% | $-14.2M |
| Sold out | ULTRAGENYX PHARMACEUTICAL IN | -379,303 | -100.0% | $-13.7M |
| Sold out | BRIDGEBIO PHARMA INC | -390,644 | -100.0% | $-13.5M |
| Sold out | PERRIGO CO PLC | -479,517 | -100.0% | $-13.4M |
| Sold out | ROIVANT SCIENCES LTD | -1,300,000 | -100.0% | $-13.1M |
| Sold out | TEVA PHARMACEUTICAL INDS LTD | -801,806 | -100.0% | $-12.3M |
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | N/AN/A | 0 | $0 | – |